Biocomposite Inks for 3D Printing
Three-dimensional (3D) printing has evolved massively during the last years. The 3D printing technologies offer various advantages, including: i) tailor-made design, ii) rapid prototyping, and iii) manufacturing of complex structures. Importantly, 3D printing is currently finding its potential in ti...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Book Chapter |
| Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04166naaaa2200901uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_76656 | ||
| 005 | 20220111 | ||
| 020 | |a books978-3-0365-1737-7 | ||
| 020 | |a 9783036517384 | ||
| 020 | |a 9783036517377 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-1737-7 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 072 | 7 | |a KNTX |2 bicssc | |
| 100 | 1 | |a Carrasco, Gary |4 edt | |
| 700 | 1 | |a Carrasco, Gary |4 oth | |
| 245 | 1 | 0 | |a Biocomposite Inks for 3D Printing |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 electronic resource (213 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Three-dimensional (3D) printing has evolved massively during the last years. The 3D printing technologies offer various advantages, including: i) tailor-made design, ii) rapid prototyping, and iii) manufacturing of complex structures. Importantly, 3D printing is currently finding its potential in tissue engineering, wound dressings, tissue models for drug testing, prosthesis, and biosensors, to name a few. One important factor is the optimized composition of inks that can facilitate the deposition of cells, fabrication of vascularized tissue and the structuring of complex constructs that are similar to functional organs. Biocomposite inks can include synthetic and natural polymers, such as poly (ε-caprolactone), polylactic acid, collagen, hyaluronic acid, alginate, nanocellulose, and may be complemented with cross-linkers to stabilize the constructs and with bioactive molecules to add functionality. Inks that contain living cells are referred to as bioinks and the process as 3D bioprinting. Some of the key aspects of the formulation of bioinks are, e.g., the tailoring of mechanical properties, biocompatibility and the rheological behavior of the ink which may affect the cell viability, proliferation, and cell differentiation.The current Special Issue emphasizes the bio-technological engineering of novel biocomposite inks for various 3D printing technologies, also considering important aspects in the production and use of bioinks. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Information technology industries |2 bicssc | |
| 653 | |a bacteria biofabrication | ||
| 653 | |a 3D printing | ||
| 653 | |a tissue engineering | ||
| 653 | |a probiotic food | ||
| 653 | |a pine sawdust | ||
| 653 | |a soda ethanol pulping | ||
| 653 | |a nanocellulose | ||
| 653 | |a cytotoxicity | ||
| 653 | |a absorption | ||
| 653 | |a wound dressings | ||
| 653 | |a bioprinting | ||
| 653 | |a cellulose | ||
| 653 | |a hydrogel | ||
| 653 | |a physical cross-linking | ||
| 653 | |a 3D bioprinting | ||
| 653 | |a biocomposite ink | ||
| 653 | |a tubular tissue | ||
| 653 | |a tubular organ | ||
| 653 | |a bacterial nanocellulose | ||
| 653 | |a cellulose nanofibrils | ||
| 653 | |a cellulose nanocrystals | ||
| 653 | |a bioink | ||
| 653 | |a collagen | ||
| 653 | |a ECM | ||
| 653 | |a extracellular matrix | ||
| 653 | |a bioinks | ||
| 653 | |a biomanufacturing | ||
| 653 | |a biocomposite | ||
| 653 | |a forest-based MFC | ||
| 653 | |a fibrils | ||
| 653 | |a additive manufacturing | ||
| 653 | |a artificial limb | ||
| 653 | |a fused deposition modeling (FDM) | ||
| 653 | |a biofabrication | ||
| 653 | |a hydrogels | ||
| 653 | |a growth factor cocktail | ||
| 653 | |a bioactive scaffold | ||
| 653 | |a printability | ||
| 653 | |a carboxylated agarose | ||
| 653 | |a free-standing | ||
| 653 | |a human nasal chondrocytes | ||
| 653 | |a clinical translational | ||
| 653 | |a polyhydroxyalkanoates | ||
| 653 | |a scaffolds | ||
| 653 | |a biomedicine | ||
| 653 | |a drug delivery | ||
| 653 | |a vessel stenting | ||
| 653 | |a cancer | ||
| 653 | |a 3D cell culture | ||
| 653 | |a CNF | ||
| 653 | |a cancer stemness | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4103 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/76656 |7 0 |z DOAB: description of the publication |